Today’s stock recommendations feature a mix of picks from the pharmaceutical, insurance, and chemicals sectors.

The US healthcare system under Trump 2.0 are likely to benefit Indian players, except for the push for increased US drug ...

CLSA analysts upgraded Aurobindo Pharma (NSE:ARBN) (ARBP:IN) stock rating from Hold to Outperform, despite reducing the price target to INR1,400 from INR1,540. The revision reflects a modified ...

Healthcare stocks see mixed performance as Dr Lal Pathlabs and Aurobindo Pharma rise over 2% after CLSA upgrades their ...

Shares of several companies including BPCL, HDFC Bank, HUL, Polycab India, Persistent Systems, Aurobindo Pharma, among others ...

Reuters Nifty continues to climb a wall of worry as it looks to be in the final leg of its rally before heading for a ...

Aurobindo Pharma Ltd is quoting at Rs 1197.8, up 1.65% on the day as on 12:49 IST on the NSE. The stock is up 5.66% in last one year as compared to a 9.94% jump in NIFTY and a 26.31% jump in the Nifty ...

Stocks like Jio Financial Services, Can Fin Homes, Seshasayee Paper, Supreme Petrochem, 5paisa Capital, ICICI Lombard General ...

Aurobindo Pharma Ltd.'s share price logging 14.6% fall in the last six months has driven Investec to initiate a 'fast long' on the stock, as it sees a depreciating rupee scenario to benefit, given its ...

Aurobindo also has the highest contribution from the exports market among Indian pharma companies, and a depreciating rupee ...